1. Home
  2. ICUI

as 04-17-2025 4:00pm EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Founded: 1984 Country:
United States
United States
Employees: N/A City: SAN CLEMENTE
Market Cap: 3.6B IPO Year: 1992
Target Price: $199.67 AVG Volume (30 days): 340.0K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -4.83 EPS Growth: N/A
52 Week Low/High: $93.36 - $196.26 Next Earning Date: 05-06-2025
Revenue: $2,382,046,000 Revenue Growth: 5.44%
Revenue Growth (this year): 0.84% Revenue Growth (next year): 2.91%

ICUI Daily Stock ML Predictions

Share on Social Networks: